Atlas Trials

A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

Clinical trial NCT06174987 · RECRUITING

Trial details

NCT number
NCT06174987
Sponsor
Daiichi Sankyo
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced CancerMetastatic Cancer
Start date
2024-01-05
Primary completion
2026-08-03
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.